SCHEMBL20109261

SCHEMBL20109261

C=CCC(NC(=O)OC(C)(C)C)C(=O)CC

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
CTSK P43235 12/20 0.44
CTSS P25774 6/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
MAPT P10636 1/20 0.38
CAPN1 P07384 1/20 0.38
ACE P12821 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23049413 0.88 SMN1; SMN2 (0.45) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL7519614 0.88 SMN1; SMN2 (0.44) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL4038634 0.87 SMN1; SMN2 (0.46) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL4038638 0.87 SMN1; SMN2 (0.46) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL7447397 0.86 SMN1; SMN2 (0.43) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL10256486 0.85 SMN1; SMN2 (0.45) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL616662 0.84 SMN1; SMN2 (0.54) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL616663 0.84 SMN1; SMN2 (0.54) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9
SCHEMBL212772 0.84 CTSK (0.47) SMN1; SMN2CTSKCTSSCA1CA2
SCHEMBL15083313 0.84 SMN1; SMN2 (0.49) SMN1; SMN2CTSKCTSSCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786165-A1 SYNTHETIC INTERMEDIATES FOR PRODUCING MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2021-03-03 EP disclosed
EP-2534154-B1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-08-05 EP disclosed
EP-2534152-B1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-02 EP disclosed